Becton Dickinson’s Vacutainer Gets EUA for COVID-19

Becton Dickinson has received Emergency Use Authorization from the FDA for its BD Vacutainer Plus Citrate Plasma Tubes for hospitalized COVID-19 patients who need to be tested for coagulopathy — a condition in which the blood’s ability to form clots is impaired.

The Vacutainer, which is manufactured in the U.K., is a sodium citrate blood specimen collection tube used to transport and store blood samples for testing.

The specimen collection tubes are currently in short supply because of the increased demand during the public health emergency, the agency said.